Cargando…
Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19
Autores principales: | Yao, Yao, Ye, Fei, Li, Kailong, Xu, Peng, Tan, Wenjie, Feng, Quansheng, Rao, Shuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897877/ https://www.ncbi.nlm.nih.gov/pubmed/33619245 http://dx.doi.org/10.1038/s41392-021-00519-1 |
Ejemplares similares
-
The 3p21.31 genetic locus promotes progression to type 1 diabetes through the CCR2/CCL2 pathway
por: Tran, Paul MH., et al.
Publicado: (2021) -
Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus
por: Kasela, Silva, et al.
Publicado: (2021) -
Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus
por: Kasela, Silva, et al.
Publicado: (2021) -
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
por: Permuth-Wey, Jennifer, et al.
Publicado: (2013) -
Genome-Wide Association Study Implicates Chromosome 9q21.31 as a Susceptibility Locus for Asthma in Mexican Children
por: Hancock, Dana B., et al.
Publicado: (2009)